Ishizuya, Asami
Enomoto, Minori
Tachimori, Hisateru
Takahashi, Hidehiko
Sugihara, Genichi
Kitamura, Shingo
Mishima, Kazuo
Funding for this research was provided by:
The Japanese Ministry of Health, Labour and Welfare (H29-Seishin-Ippan-001)
Article History
Received: 29 October 2020
Accepted: 6 January 2021
First Online: 18 January 2021
Competing interests
: SK has received research support from the Japanese Ministry of Education, Sports, Science and Technology (17K07597). SK has received lecture fees from Otsuka Pharmaceutical Co., Ltd., and research funding from Boehringer Ingelheim Japan, Inc., VELDT Inc., and Tsubota Laboratory Inc. HT received a joint research grant from FUJIFILM Corporation. KM has received research support from the Japanese Ministry of Health, Labour and Welfare (H29-Seishin-Ippan-001, 19GC1012), the Japanese Ministry of Education, Sports, Science and Technology (19H03578), and a National Center of Neurology and Psychiatry Intramural Research Grant for Neurological and Psychiatric Disorders (29-1). KM has also received a collaborative research fund from the WPI-International Institute for Integrative Sleep Medicine, University of Tsukuba, and Taisho Pharmaceutical Co., Ltd. KM has received speaker’s honoraria from Eisai Co., Ltd., MSD Inc., Takeda Pharmaceutical Co., Ltd., Astellas Pharma Inc., Pfizer Inc., Otsuka Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation (Yoshitomiyakuhin Corporation), and Janssen Pharmaceutical along with research grants from Eisai Co., Ltd., Nobelpharma Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd. GS has received research support from the Japanese Ministry of Education, Sports, Science and Technology (18K07597). The remaining authors declare no competing interests.